EUVIMEDTutustu EUVIMEDiin
Vergleichsstudie

Comparative Outcomes of Left Atrial Appendage Occlusion Device Implantation in Atrial Fibrillation Patients With Lower Stroke Risk

Amanda Nguyen, Muhammad Zia Khan, Waleed Alruwaili, Muhammad Usman Khan iD, Muhammad Bilal iD, Salman Zahid, Karthik Gonuguntla, Samrina Khan, Melody Mendez, Zain Ul Abideen Asad, Siddharth Agarwal, Sudarshan Balla and 2 more

Pacing and Clinical Electrophysiology · 2026-07 · 49 (7) · 842-850

DOI: 10.1111/pace.70184 ↗

At a glance

Vergleichsstudie in Pacing and Clinical Electrophysiology, published online on 2026-02-25. Written by Amanda Nguyen and 13 co-authors. Institution: Department of Medicine, University of California Davis Medical Center, Sacramento, California, USA. Major MEDLINE topics: Atrial Fibrillation, Left Atrial Appendage Closure, Stroke, Atrial Appendage. 27 references.

TiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

Background

Current guidelines recommend oral anticoagulation in atrial fibrillation (AF) patients with a CHA 2 DS 2 ‐VASc score ≥2 for stroke prevention. However, Centers for Medicare & Medicaid Services (CMS) reimburses left atrial appendage occlusion (LAAO) for patients with CHA 2 DS 2 ‐VASc score ≥3. This study aimed to evaluate differences in outcomes and complications of LAAO therapy in AF patients with a CHA 2 DS 2 ‐VASc score of ≥ 3 versus < 3.

Methods

National Inpatient Sample (NIS) and International Classification of Diseases, Tenth Revision codes were used to identify LAAO device implantation in the U.S. from years 2016 to 2020. The study population was stratified by stroke risk into two groups, CHA 2 DS 2 ‐VASc ≥ 3 and < 3. Study endpoints assessed included procedural complications, inpatient outcomes and resource utilization.

Results

A total of 73,795 and 15,500 LAAO devices were implanted in patients with CHA 2 DS 2 ‐VASc ≥ 3 and < 3, respectively. Compared to patients with CHA 2 DS 2 ‐VASc score of ≥ 3, patients with CHA 2 DS 2 ‐VASc < 3 had lower overall (6.9% vs 9.9%, P < 0.01) and major (4.5% vs 6.2%, P < 0.01) complications in the crude analysis. After multivariable adjustment for potential confounders, CHA 2 DS 2 ‐VASc < 3 was associated with lower overall complications (aOR 0.84, 95% CI 0.78 – 0.91), major complications (aOR 0.90, 95% CI 0.81–0.99) and cost of hospitalization (aOR 0.95, 95% CI 0.91–0.99).

Conclusions

Patients with CHA 2 DS 2 ‐VASc < 3 had lower complications and hospitalization costs after LAAO device implantation. These data, if redemonstrated in a large randomized trial, can have important clinical implications for stroke prevention in AF patients.

Subjects

MeSH terms (MEDLINE)

Atrial FibrillationLeft Atrial Appendage ClosureStrokeAtrial AppendageHumansFemaleMaleAgedTreatment OutcomeUnited StatesAged, 80 and overRisk FactorsRisk Assessment

Author keywords

atrial fibrillationcomplicationsleft atrial appendage occlusionoutcomesstroke risk

Authors and institutions

  • Department of Medicine, University of California Davis Medical Center, Sacramento, California, USA.
  • Division of Cardiology, Deborah Heart and Lung Center, Browns Mills, New Jersey, USA.
  • Division of Cardiology, West Virginia University Heart and Vascular Institute, Morgantown, West Virginia, USA.
  • Division of Cardiology, University of Florida Jacksonville, Jacksonville, Florida, USA.
  • Department of Medicine, Merit Health Wesley, Hattiesburg, Mississippi, USA.
  • Division of Cardiology, Oregon Health and Science University, Portland, Oregon, USA.

ORCID profiles: Muhammad Usman Khan, Muhammad Bilal

Cite

APA

Nguyen, A., Khan, M. Z., Alruwaili, W., Khan, M. U., Bilal, M., Zahid, S., Gonuguntla, K., Khan, S., Mendez, M., Asad, Z. U. A., Agarwal, S., Balla, S., Darden, D., & Munir, M. B. (2026). Comparative Outcomes of Left Atrial Appendage Occlusion Device Implantation in Atrial Fibrillation Patients With Lower Stroke Risk. Pacing and Clinical Electrophysiology, 49(7), 842-850. https://doi.org/10.1111/pace.70184

Vancouver

Nguyen A, Khan MZ, Alruwaili W, Khan MU, Bilal M, Zahid S, et al. Comparative Outcomes of Left Atrial Appendage Occlusion Device Implantation in Atrial Fibrillation Patients With Lower Stroke Risk. Pacing and Clinical Electrophysiology. 2026;49(7):842-850. doi:10.1111/pace.70184

BibTeX
@article{Nguyen2026,
  author = {Nguyen, Amanda and Khan, Muhammad Zia and Alruwaili, Waleed and Khan, Muhammad Usman and Bilal, Muhammad and Zahid, Salman and Gonuguntla, Karthik and Khan, Samrina and Mendez, Melody and Asad, Zain Ul Abideen and Agarwal, Siddharth and Balla, Sudarshan and Darden, Douglas and Munir, Muhammad Bilal},
  title = {Comparative Outcomes of Left Atrial Appendage Occlusion Device Implantation in Atrial Fibrillation Patients With Lower Stroke Risk},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2026},
  volume = {49},
  number = {7},
  pages = {842--850},
  doi = {10.1111/pace.70184}
}
Start for free →